Advertisement

Topics

Patheon Inc. Company Profile

19:15 EDT 25th September 2018 | BioPortfolio

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Patheon, a DPx business unit, encompasses the combined CMO capabilities and pharmaceutical product development services (PDS), as well as the Biosolutions and Biologics (BIO) business. For more information visit http://www.patheon.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Patheon Expands Offerings and Capacity at Milton Park, UK Facility

Patheon, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, is increasing solid dose capabilities at its European sites. The lat...

Editas Medicine names James Mullen as chairman

He has previously served as CEO of Patheon

PTV News: Oct 20, 2009

Top stories on October 20th, 2009: Roche products re-branded Genentech in US Lonza drops US$ 460m bid for Patheon Boehringer's Micardis gets CVD sales boost AstraZeneca staff to "self-identify" them...

PTV News: Aug 24, 2009

Top stories on August 24th, 2009: The $3 billion price tag for Proctor and Gamble’s prescription drug business How much is Patheon worth? Lonza bids 460 million Dollar. Combining cell therapy and ...

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Hydroxyzine pamoate [Watson Laboratories, Inc.]

70010463 HydrOXYzine Pamoate Capsules, USP Rx only

Azelastine hydrochloride [Wallace Pharmaceuticals Inc.]

Azelastine HydrochlorideOphthalmic Solution, 0.5%

Optivar [Meda Pharmaceuticals Inc.]

OPTIVAR azelastine hydrochloride ophthalmic solution, 0.05%

70010599meclizine hcitablets usprx only [Watson Laboratories, Inc.]

70010599Meclizine HCITablets USPRx only

Hydroxyzine pamoate [Preferred Pharmaceuticals, Inc]

HydrOXYzine Pamoate Capsules, USP

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Seqirus 2017 H7N9 With/Without MF59 (R) in Healthy Males and Non-pregnant Females, 18-64 Years of Age.

This is a randomized, double-blinded, Phase II study in healthy males and non-pregnant females, 18-64 years of age. This clinical trial is designed to assess the safety, reactogenicity, an...

Companies [4 Associated Companies listed on BioPortfolio]

Patheon Inc.

Patheon is a leading provider of contract development and commercial manufacturing (CDMO) services to the global pharmaceutical industry for a full array of solid and sterile dosa...

Patheon N.V.

Patheon is a leading global provider of pharmaceutical development and manufacturing services. With approximately 9,100 employees and contractors worldwide, Patheon provides a com...

Patheon

Patheon, based in Toronto, Canada, is a leading international provider of pharmaceutical contract manufacturing and development services. Established in 1974, Patheon has grown into a fully integrated...

JLL Patheon Holdings, LLC

More Information about "Patheon Inc." on BioPortfolio

We have published hundreds of Patheon Inc. news stories on BioPortfolio along with dozens of Patheon Inc. Clinical Trials and PubMed Articles about Patheon Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Patheon Inc. Companies in our database. You can also find out about relevant Patheon Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record